HIGH

BBraun Medical Blood Administration Set Recall 5,448 Units (2025)

BBraun Medical recalled 5,448 Blood Administration Sets used with Infusomat Space pumps worldwide sold to hospitals. The recall cites potential backflow of medication from secondary piggyback IV containers into primary IV containers and an inability to prime. Healthcare facilities should stop using the sets immediately and follow recall instructions from B. Braun Medical.

Quick Facts at a Glance

Recall Date
October 29, 2025
Hazard Level
HIGH
Brand
B. Braun Medical
Category
Health & Personal Care
Sold At
Unknown
At-Risk Groups
GENERAL

Hazard Information

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact B Braun Medical Inc or your healthcare provider for instructions. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Blood administration sets are used to deliver blood products and IV fluids in hospitals. They connect to pumps or gravity feeds for controlled infusion.

Why This Is Dangerous

Backflow from secondary to primary IV containers and failure to prime can lead to misdelivery of medications or volume errors.

Industry Context

This recall is not indicated as part of a broader industry pattern.

Real-World Impact

Hospitals may need to halt use and replace inventory, which can affect patient care workflow and supply management.

Practical Guidance

How to identify if yours is affected

  1. Check Catalog Number 480233 on the product label.
  2. Verify Primary UDI-DI 04046955083572.
  3. Verify Unit of Dose UDI-DI 04046955083565.
  4. Confirm distribution regions include the US, Canada, Germany, Guatemala, Singapore.

Where to find product info

Recall notification letter and FDA enforcement page linked in the recall notice.

What timeline to expect

4-6 weeks for processing and refunds/replacements where applicable.

If the manufacturer is unresponsive

  • Document all contact attempts
  • Escalate to hospital compliance or regulatory authorities if the vendor is unresponsive
  • Use FDA recall resources for guidance and reporting if needed

How to prevent similar issues

  • Maintain an up-to-date inventory of UDIs and catalog numbers
  • Implement a recall-specific quarantine process for affected lots
  • Train staff on identifying recall notices and follow-up procedures

Documentation advice

Keep the recall letter, inventory lists, and correspondence with the supplier; photograph packaging and catalog labels for records.

Product Details

Catalog Number: 480233. Primary UDI-DI: 04046955083572. Unit of Dose UDI-DI: 04046955083565. Sold worldwide, including US distribution and international distribution to Canada, Germany, Guatemala, and Singapore. Sold since: Unknown. Price: Unknown.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 5,448 units recalled
  • Catalog Number 480233
  • Primary UDI-DI 04046955083572
  • Unit of Dose UDI-DI 04046955083565
  • Worldwide distribution including US, Canada, Germany, Guatemala, Singapore

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
Catalog Number: 480233
Primary UDI-DI: 04046955083572
Unit of Dose UDI-DI: 04046955083565
Report Date
December 3, 2025
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more